BRIEF published on 04/20/2026 at 07:35, 10 days 20 hours ago Last day for exercising Nicox warrants: June 19, 2026 Euronext Growth Deadline Share Subscription Ophthalmology BSA Nicox
BRIEF published on 04/20/2026 at 07:35, 10 days 20 hours ago Nicox Sets Deadline for June 2024 Warrants Exercise Warrants Shares Euronext Nicox Exercise Deadline
PRESS RELEASE published on 04/20/2026 at 07:30, 10 days 21 hours ago Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 Nicox SA reminds warrant holders of the upcoming expiration date on June 19, 2026. The warrants, with ISIN code FR001400QEQ3, provide the right to subscribe to new shares at €0.275 per share Euronext Growth Paris Warrants Equity Offering Expiration Date Nicox SA
BRIEF published on 02/24/2026 at 07:35, 2 months 4 days ago Nicox Reveals Positive Phase 3 Results for NCX 470 at AGS Meeting Glaucoma Phase 3 Study NCX 470 Intraocular Pressure Therapeutic Profile
PRESS RELEASE published on 02/24/2026 at 07:30, 2 months 4 days ago Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
BRIEF published on 02/16/2026 at 07:35, 2 months 12 days ago Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion FDA Glaucoma NDA Nicox NCX 470
BRIEF published on 02/16/2026 at 07:35, 2 months 12 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
PRESS RELEASE published on 02/16/2026 at 07:30, 2 months 12 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 2 months 16 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/10/2026 at 07:35, 2 months 18 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
Published on 05/01/2026 at 04:00, 34 minutes ago Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 1 hour 9 minutes ago McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 1 hour 39 minutes ago GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 3 hours 34 minutes ago PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 00:45, 3 hours 49 minutes ago Inventus Announces Closing of $2.5 Million Non-Brokered Flow-Through Financing
Published on 04/30/2026 at 23:39, 4 hours 55 minutes ago Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 22:35, 5 hours 59 minutes ago Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Published on 04/30/2026 at 22:04, 6 hours 30 minutes ago Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 9 hours 33 minutes ago DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 9 hours 34 minutes ago BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
Published on 04/30/2026 at 20:00, 8 hours 33 minutes ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 9 hours 18 minutes ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 9 hours 34 minutes ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 10 hours 24 minutes ago Minutes of the Combined General Meeting held on April 30, 2026
